Inhalation Product Technology Centre (IPTC) from Presspart

Supporting the strategic projects of Presspart and our customers

Here at Presspart Manufacturing, we have further expanded our research and development capabilities with the introduction of an Inhalation Product Technology Centre (IPTC).

As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters and plastic metered-dose inhaler actuators, the new Inhalation Product Technology Centre, which is a first for the industry, will help support the strategic projects of Presspart and most importantly its customers.

Our IPTC will deliver the capabilities to support new product developments and strategic initiatives with our customers. Presspart has an in-depth technical understanding of the products we manufacture and assembly and IPTC will enhance those capabilities and deliver a customer focused device development and drug related performance understanding.

Key Capabilities of IPTC will include:

  • Inhalation Device Design, Concept and Development
  • Device customisation and enhancement to meet formulation requirements
  • Device performance / interaction studies with the drug product
  • Device meteorology and specification development
  • Component / device evaluation, screening and optimization
  • Inhalation product testing support
  • Multi region regulatory support
Automatic MDI shaker machine in our IPTC lab

The new IPTC will be headed up by Ameet Sule, who will be based at Presspart Blackburn at the IPTC headquarters, which include extensive offices, research and laboratory facilities as well as a dedicated team to work within the Inhalation Product Technology Centre.

Ameet holds a Masters in Chemistry from Mumbai University, and joins the company from Lupin, where he held the position of Director Pulmonary Research. Ameet is a R&D professional with over 19 years of experience encompassing the development of MDI components, formulations, analytical methods and drug products.